Recent advances in the administration of vaccines for infectious diseases: Microneedles as painless delivery devices for mass vaccination

Drug Discovery Today

Volumn 16, Issue 23-24, 2011, Pages 1061-1068

  Hegde, Nagendra R ^a   Kaveri, Srinivas V ^b,c,d   Bayry, Jagadeesh ^b,c  

^a Ella Foundation   (India)

^b INSERM   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; VACCINE;

DEVICE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; HUMAN; INFECTION; INFECTION CONTROL; INFECTION PREVENTION; NEEDLE; NONHUMAN; REVIEW; VACCINATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; COMMUNICABLE DISEASES; DRUG DELIVERY SYSTEMS; HUMANS; MASS VACCINATION; MICROINJECTIONS; NEEDLES; VACCINES;

EID: 82255162900     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2011.07.004     Document Type: Review

References (109)

1. S.A. Plotkin Correlates of protection induced by vaccination Clin. Vac. Immunol. 17 2010 1055 1065
2. J.N. Zuckerman The importance of injecting vaccines into muscle: different patients need different needle sizes BMJ 321 2000 1237 1238
3. M. Nino Topical delivery of active principles: the field of dermatological research Dermatol. Online J. 16 2010 4
4. N. Romani Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy Immunol. Cell Biol. 88 2010 424 430
5. S. Henri Disentangling the complexity of the skin dendritic cell network Immunol. Cell Biol. 88 2010 366 375
6. H. Ueno Dendritic cells and humoral immunity in humans Immunol. Cell Biol. 88 2010 376 380
7. I.M. Belyakov Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells J. Clin. Invest. 113 2004 998 1007 (Pubitemid 38544121)
8. P.L. Ogra Vaccination strategies for mucosal immune responses Clin. Microbiol. Rev. 14 2001 430 445 (Pubitemid 32294678)
9. M. Rescigno, and A. Sabatino Dendritic cells in intestinal homeostasis and disease J. Clin. Invest. 119 2009 2441 2450
10. H. Kiyono, and S. Fukuyama NALT-versus Peyer's-patch-mediated mucosal immunity Nat. Rev. Immunol. 4 2004 699 710 (Pubitemid 39223076)
11. P. Brandtzaeg The mucosal immune system and its integration with the mammary glands J. Pediatr. 156 2010 8 15
12. E.L. Giudice, and J.D. Campbell Needle-free vaccine delivery Adv. Drug Deliv. Rev. 58 2006 68 89
13. J.C. Birchall Microneedle array technology: the time is right but is the science ready? Expert Rev. Med. Dev. 3 2006 1 4
14. M.R. Prausnitz, and R. Langer Transdermal drug delivery Nat. Biotechnol. 26 2008 1261 1268
15. M.A. Kendall Needle-free vaccine injection Handb. Exp. Pharmacol. 197 2010 193 219
16. R.K. Sivamani Microneedles and transdermal applications Expert Opin. Drug Deliv. 4 2007 19 25 (Pubitemid 46117483)
17. R.F. Donnelly Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety Drug Deliv. 17 2010 187 207
18. Kim, Y.C. et al. (2011) Delivery systems for intradermal vaccination. Curr. Topics Microbiol. Immunol. (Epub ahead of print, April 7, 2011) PMID: 21472533
19. H.S. Gill, and M.R. Prausnitz Does needle size matter? J. Diabetes Sci. Technol. 1 2007 725 729
20. ® 33-gauge needle for insulin therapy J. Diabetes Sci. Technol. 1 2007 718 724
21. S. Henry Microfabricated microneedles: a novel approach to transdermal drug delivery J. Pharm. Sci. 87 1998 922 925 (Pubitemid 28381247)
22. S.A. Coulman Minimally invasive cutandous delivery of macromolecules and plasmid DNA via microneedles Curr. Drug Deliv. 3 2006 65 75
23. H.S. Gill Effect of microneedle design on pain in human volunteers Clin. J. Pain 24 2008 585 594
24. M.I. Haq Clinical administration of microneedles: skin puncture, pain and sensation Biomed. Microdevices 11 2009 35 47
25. S.A. Coulman In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography Pharm. Res. 28 2011 66 81
26. A.J. Harvey Microneedle-based intradermal delivery enables rapid lymphatic uptake and distribution of protein drugs Pharm. Res. 28 2011 107 116
27. J.W. Lee Dissolving microneedle patch for transdermal delivery of human growth hormone Small 7 2011 531 539
28. S. Kaushik Lack of pain associated with microfabricated microneedles Anesth. Analg. 92 2001 502 504 (Pubitemid 32127644)
29. M.R. Prausnitz Current status and future potential of transdermal drug delivery Nat. Rev. Drug Discov. 3 2004 115 124 (Pubitemid 38239773)
30. P.M. Wang Precise microinjection into skin using hollow microneedles J. Invest. Dermatol. 126 2006 1080 1087
31. M.R. Prausnitz Microneedle-based vaccines Curr. Top. Microbiol. Immunol. 333 2009 369 393
32. H.S. Gill, and M.R. Prausnitz Coating formulations for microneedles Pharm. Res. 24 2007 1369 1380 (Pubitemid 46870599)
33. J.H. Park Polymer particle-based micromolding to fabricate novel microstructures Biomed. Microdevices 9 2007 223 234
34. J.W. Lee Dissolving microneedles for transdermal drug delivery Biomaterials 29 2008 2113 2124
35. H.S. Gill, and M.R. Prausnitz Pocketed microneedles for drug delivery to the skin J. Phys. Chem. Solids 69 2008 1537 1541
36. E.M. Saurer Layer-by-layer assembly of DNA- and protein-containing films on microneedles for drug delivery to the skin Biomacromolecules 11 2010 3136 3143
37. T. Miyano Sugar microneedles as transdermic drug deliver system Biomed. Microdevices 7 2005 185 188 (Pubitemid 41236286)
38. K. Fukushima Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats Pharm. Res. 28 2011 7 21
39. K. Fukushima Pharmaco-kinetic and pharmacodynamic evaluation of insulin dissolving microneedles in dogs Diabetes Technol. Ther. 12 2010 465 474
40. W. Zhang Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles Int. J. Pharm. 402 2010 205 212
41. L.Y. Chu Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: bubble and pedestal microneedle designs J. Pharm. Sci. 99 2010 4428 4438
42. L.Y. Chu, and M.R. Prausnitz Separable arrowhead microneedles J. Control. Release 149 2011 242 249
43. U. Carlsson Hepatitis A vaccination by intracutaneous low dose administration: a less expensive alternative Scand. J. Infect. Dis. 28 1996 435 438 (Pubitemid 26393581)
44. C. Panchareon Reduced-dose intradermal vaccination against hepatitis A with an aluminum-free vaccine is immunogenic and can lower costs Clin. Infect. Dis. 41 2005 1537 1540
45. L. Sangare Intradermal hepatitis B vaccination: a systematic review and meta-analysis Vaccine 27 2009 1777 1786
46. O. Launay Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial JAMA 305 2011 1432 1440
47. O. Launay Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC-16 trial PLoS ONE 2 2007 e725
48. R.B. Belshe Serum antibody responses after intradermal vaccination against influenza N. Engl. J. Med. 351 2004 2286 2294 (Pubitemid 39552744)
49. R.B. Belshe Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults Vaccine 25 2007 6755 6763 (Pubitemid 47332726)
50. V. Vankerckhoven, and P. van Damme Clinical studies assessing immuno-genicity and safety of intradermally administered influenza vaccines Expert Opin. Drug Deliv. 7 2010 1109 1125
51. F.T. Cutts Alternative routes of measles immunization: a review Biologicals 3 1997 323 338 (Pubitemid 27453255)
52. N. Etchart Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans Vaccine 25 2007 6891 6899 (Pubitemid 47391105)
53. A.J. Mohammed Fractional doses of inactivated poliovirus vaccine in Oman N. Engl. J. Med. 362 2010 2351 2359
54. S. Resik Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba J. Infect. Dis. 201 2010 1344 1352
55. D. Brown Intradermal pre-exposure rabies vaccine elicits long lasting immunity Vaccine 26 2008 3909 3912
56. A.H. Roukens Reduced dose pre-exposure primary and booster intradermal rabies vaccination with a purified chick embryo cell vaccine (PCECV) is immunogenic and safe in adults Vaccine 26 2008 3438 3442
57. X. Wu Development of combined vaccines for rabies and immunocontraception Vaccine 27 2009 7202 7209
58. P.E. Laurent Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults Vaccine 28 2010 5850 5856
59. G. Sampath Immunogenicity and safety study of Indirab: a Vero cell based chromatographically purified human rabies vaccine Vaccine 28 2010 4086 4090
60. Warrell, M.J. (2011) Intradermal rabies vaccination: the evolution and future of pre- and post-exposure prophylaxis. Curr. Topics Microbiol. Immunol. (Epub ahead of print, 26 January, 2011) PMID: 21267707
61. D.A. Henderson Smallpox and vaccinia S. Plotkin, Vaccines Vol. 5 2008 Elsevier 773 803
62. D.F. Hoft A new recombinant bacilli Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers J. Infect. Dis. 198 2008 1491 1501
63. S.L. Baldwin Intradermal immunication improves protective efficacy of a novel TB vaccine candidate Vaccine 23 2009 3063 3071
64. Roukens, A.H. et al. (2011) Intradermal vaccination to protect against yellow fever and influenza. Curr. Topics Microbiol. Immunol. (Epub ahead of print, 17 March, 2011) PMID: 21416266
65. J.B. Alarcon Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines Clin. Vac. Immunol. 14 2007 375 381 (Pubitemid 46732547)
66. D. Holland Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial J. Infect. Dis. 198 2008 650 658
67. I. Leroux-Roels Seasonal influenza vaccine delivered by intradermal microinjection: a randomized controlled safety and immunogenicity trial in adults Vaccine 26 2008 6614 6619
68. R. Arnou Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study Vaccine 27 2009 7304 7312
69. J. Beran Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomized controlled safety and immunogenicity trial BMC Med. 7 2009 13
70. Y.C. Kim Improved influenza vaccination in the skin using vaccine coated microneedles Vaccine 27 2009 6932 6938
71. D.G. Koutsonanos Transdermal influenza immunization with vaccine-coated microneedle arrays PLoS ONE 4 2009 e4773
72. F.S. Quan Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin PLoS ONE 4 2009 e7152
73. P. van Damme Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults Vaccine 27 2009 454 459
74. Q. Zhu Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge Proc. Natl. Acad. Sci. U. S. A. 106 2009 7968 7973
75. Y.C. Kim Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity J. Control. Release 142 2010 187 195
76. Y.C. Kim Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles J. Infect. Dis. 201 2010 190 198
77. Y.C. Kim Formulation of microneedles coated with influenza virus-like particle vaccine AAPS Pharm. Sci. Technol. 11 2010 1193 1201
78. Y.C. Kim Stability kinetics of influenza vaccine coated onto microneedles during drying and storage Pharm. Res. 28 2011 135 144
79. M.dP. Martin Adjuvanted influenza vaccine administered intradermally elicits robust long-term immune responses that confer protection from lethal challenge PLoS ONE 5 2010 e10897
80. M. Pearton Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin Vaccine 28 2010 6104 6113
81. F.S. Quan Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization J. Virol. 84 2010 7760 7769
82. F.S. Quan Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles J. Control. Release 147 2010 326 332
83. J.M. Song Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice Clin. Vac. Immunol. 17 2010 1381 1389
84. J.M. Song Improved protection against avian influenza H5N1 virus by a single vaccine with virus-like particles in skin using microneedles Antiviral Res. 88 2010 244 247
85. S.P. Sullinvan Dissolving polymer microneedle patches for influenza vaccination Nat. Med. 16 2010 915 920
86. W.C. Weldon Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity Clin. Vac. Immunol. 18 2011 647 654
87. T.P. Monath Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen J. Infect. Dis. 188 2003 1213 1230 (Pubitemid 37338987)
88. C.H. Dean Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax-JE) in non-human primates Hum. Vaccin. 1 2005 106 111
89. J.A. Mikszta Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms J. Infect. Dis. 191 2005 278 288 (Pubitemid 40096387)
90. J.A. Mikszta Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine Infect. Immun. 74 2006 6806 6810 (Pubitemid 44913155)
91. Z. Ding Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice J. Control. Release 136 2009 71 78
92. Y. Hiraishi Bacillus Calmette-Guerin vaccination using a microneedle patch Vaccine 29 2011 2626 2636
93. J. Huang Protective immunity in mice achieved with dry powder formulation and alternative delivery of plaque F1-V vaccine Clin. Vac. Immunol. 16 2009 719 725
94. G.L. Morefield An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock J. Immune Based Ther. Vaccines 6 2008 5
95. J.A. Mikszta Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery Nat. Med. 8 2002 415 419 (Pubitemid 34407039)
96. M. Kendall Engineering of needle-free physical methods to target epidermal cells for DNA vaccination Vaccine 24 2006 4651 4656 (Pubitemid 43776781)
97. J.W. Hooper Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge Vaccine 25 2007 1814 1823 (Pubitemid 46176327)
98. H.S. Gill Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine Gene Ther. 17 2010 811 814
99. X. Chen Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microneedle arrays J. Control. Release 148 2010 327 333
100. M.L. Crichton The effect of strain rate on the precision of penetration of short densely-packed microneedle array patches coated with vaccine Biomaterials 31 2010 4562 4572
101. A.S. Kask DNA vaccine delivery by densely-packed and short microneedle arrays to skin protects against vaginal HSV-2 challenge Vaccine 28 2010 7483 7491
102. G.J. Fernando Potent immunity to low doses of influenza vaccine by probabilistic guided micro-targeted skin delivery a mouse model PLoS ONE 5 2010 e10266
103. T.W. Prow Nanopatch-targeted skin vaccination against West Nile virus and chikungunya virus in mice Small 6 2010 1776 1784
104. A.P. Raphael Targeted, needle-free vaccinations in skin using multilayered, densely packed dissolving microneedle arrays Small 6 2010 1785 1793
105. J.E. Rollenhagen Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice Infect. Immun. 74 2006 5834 5839 (Pubitemid 44484570)
106. C. Ghose Transcutaneous immunization with Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin A-neutralizing antibodies in mice Infect. Immun. 75 2007 2826 2832 (Pubitemid 46870163)
107. D.K. Hickey Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections Vaccine 27 2009 6217 6225
108. D.K. Hickey Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicopabter pylori infection Vaccine 27 2009 6983 6990
109. V. Aimanianda Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants Trends Pharmacol. Sci. 30 2009 287 295